| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.083 | 0.07 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.07 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.095 | 0.07 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |